Copper homeostasis and cuproptosis in cardiovascular disease therapeutics

Lifang Yang,Pingping Yang,Gregory Y. H. Lip,Jun Ren
DOI: https://doi.org/10.1016/j.tips.2023.07.004
IF: 17.638
2023-01-01
Trends in Pharmacological Sciences
Abstract:Copper (Cu) homeostasis is gaining increasing attention in human health as both Cu overload and deficiency evokes pathological changes including cardiovascular diseases (CVDs). Cu supplementation, nanocarriers, and chelators have all exhibited therapeutic promise in some human diseases, although how Cu dyshomeostasis and cuproptosis, a novel form of regulated cell death, contribute to CVD pathology remains elusive. Here, we discuss Cu dyshomeostasis and the potential role of cuproptosis in various CVDs. We evaluate underlying cellular mechanisms, aiming to provide some insights regarding the utility of targeting Cu dyshomeostasis and cuproptosis as a novel strategy in the management of CVDs.
What problem does this paper attempt to address?